Navigation Links
Immtech Reports Fiscal Year End 2008 Results
Date:6/18/2008

gs candidates; (viii) the success of Immtech's clinical trials; (ix) dependence upon and contractual relationship with partners; (x) Immtech's ability to protect its intellectual property; and (xi) competition and alternative technologies.

In addition, Immtech does not undertake any obligation, and specifically disclaims any obligation, to publicly update or revise forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

3 Months

Ended Year Ended

March 31, March 31,

2008 2007 2008 2007

REVENUES $ 6,025 $ 1,339 $ 9,717 $ 4,318

OPERATING INCOME

(LOSS) $ 627 $ (3,216) $ (10,952) $ (11,662)

NET INCOME (LOSS)

TO COMMON

SHAREHOLDERS $ 560 $ (3,219) $ (11,042) $ (11,683)

NET LOSS PER

COMMON SHARE

BASIC AND DILUTED

Net Income $ 0.03 $ (0.22) $ (0.71) $ (0.82)

AVERAGE COMMON

SHARES OUTSTANDING

Basic and diluted 16,946,251 14,782,004 15,477,463 14,207,048


'/>"/>
SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immtech Announces Results From Hepatitis C Discovery Program
2. Immtech Announces Update on Business Operations
3. Immtech Investor Conference Call Scheduled for February 22, 2008
4. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
5. Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
6. Immtech Completes Malaria Prevention Trial
7. PreMD Reports Further Positive Meetings with the FDA
8. Herley Reports Third Quarter Results
9. Hawkins, Inc. Reports Fourth Quarter, Fiscal 2008 Results
10. China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
11. Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Wont Cover It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Sacramento, PA (PRWEB) May 28, 2015 ... wishes and adventures. Each item on the ... absolutely impossible events, experiences and tasks that the owner ... is no right or wrong when it comes to ... starting a business, writing poems, publishing a book, seeing ...
(Date:5/28/2015)... Palmetto, FL (PRWEB) May 28, 2015 ... released a case study featuring Healthcare IQ. Members of ... Healthcare IQ senior management team to develop the case ... arena of healthcare analytics. , The case study, ‘Healthcare ... chronicles Healthcare IQ from its beginning as a hospital ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Orem, UT—Dymicron, ... in-human surgeries using their unique Triadyme-C cervical total disc ... surgeon Dr. William D. Smith at the American Institute ... “The patients are responding well to the implantation of ... of AIMIS Spine Center and Chief of Neurosurgery for ...
(Date:5/28/2015)... 2015 Aureus Medical Group (web: aureuslocumtenens.com), ... jobs, has announced that it will participate as an ... National Conference to be held June 9-14, 2015 in ... programming, networking opportunities, and exhibits with products and services. ... division will be available to speak with attendees ...
(Date:5/28/2015)... NY (PRWEB) May 28, 2015 Peggy J. ... Chief Delegate to the American Physical Therapy Association House of ... the Delegation at their Delegate Assembly. This will be ... of Delegates serves as coordinator and principle spokesperson for the ... The Board of Directors or Delegate Assembly may direct the ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... Treat Diseases (HTDS) www.htdsmedical.com is pleased to ... Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope). ... corporation; HTDS Enterprises, Inc., which is the parent company ... million USD on an all-stock basis. The company will ...
... Misonix, Inc. (Nasdaq: MSON ), a developer ... Europe is used for the ablation of tumors and ... a new, three year, exclusive distribution agreement with privately-held ... Saba, Israel, for the distribution of the SonaStar(TM) Ultrasonic ...
... Consumer Watchdog sent a letter to Senator ... expressing their profound disappointment that consumer advocates had ... the Massachusetts senator to formulate health care reform ... recent national polls showing the public overwhelming opposed ...
... Well Asthma is Controlled in New EnglandPROVIDENCE, R.I., Feb. ... (ALANE) has partnered with QualityMetric Incorporated of Lincoln, Rhode ... that will help asthma sufferers learn how well their ... the results with their physician.The Asthma Control Test(TM) (ACT(TM)) ...
... QINGDAO, China and ROCKVILLE, Md., Feb. 20 ... SYUT , "Synutra"), a leading infant formula,company ... seller of nutritional products,for infants, children and ... of certain production permit numbers in a ...
... Inc., (OTC Bulletin Board: EFSF) an emerging healthcare ... dermatology, environmental and nutraceutical products, outlined its growth ... 2010 during its regularly scheduled monthly investor call, ... intends to increase revenues by improving the visibility ...
Cached Medicine News:Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 2Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 3Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:Consumer Watchdog to U.S. Senate: Don't Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone 2Health News:American Lung Association of New England Launches Online Asthma Control Test 2Health News:American Lung Association of New England Launches Online Asthma Control Test 3Health News:American Lung Association of New England Launches Online Asthma Control Test 4Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 2Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 3Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 2Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 3
(Date:5/28/2015)... 2015  Pharmaceutic Labs announces its official status ... of the FDA,s Drug Quality and Security Act. ... subject to Current Good Manufacturing Practice (CGMP) and ... the highest standards of CGMP 21 CFR Part ... comply with FDA regulations and ensure patient safety, ...
(Date:5/28/2015)... RARITAN, N.J. , May 28, 2015  Janssen ... today announced the initiation of CALLISTO, a new comprehensive ... in patients with active cancer. The studies are evaluating ... blood clots in patients with a wide range of ... the risk of venous thromboembolism (VTE), which is a ...
(Date:5/28/2015)... May 28, 2015  Cardinal Health today announced that ... & Johnson,s Cordis business for $1.944 billion in cash ... with relevant works councils and trade unions. The transaction ... States and key non-U.S. countries towards the ... customary closing conditions. Headquartered in ...
Breaking Medicine Technology:New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 4New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 5New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 6New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 7New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 8New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 9New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 10New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 11New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 12Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4
... Aug. 20 Do you currently have a study,that ... sites,recruitment tools and a budget for media but still ... is an extra set of hands to help,your sites ... assistance and consultation., "Through our Argonauta Assist(TM) service," ...
... SYDNEY, Australia, Aug. 20 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis ... 3 clinical trial evaluating the long term safety ... no serious,adverse events attributed to the drug following ... 123 subjects started treatment with 320 mg Bronchitol ...
Cached Medicine Technology:Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3
FREEDOM® Memory Thumb Spica lets you make a custom splint in minutes. Immerese in 160 F water until pliable, and remove. Amazingly, it maintains its shape and is ready to be precisely, profession...
... Freedom® CMC ThumbFit™ reduces joint instability ... splint is remarkably comfortable and easy ... Kirby, OTR/L, CHT and Robert V. ... splint together in response to patients' ...
... offers thumb and wrist control in a ... Lightweight stays provide firm control at the ... contoured for proper positioning and fit. Ideal ... CMC joint arthritis, and following cast removal. ...
... Soft, foam-lined FoamWrap ThumWrap Splints offer support ... Ideal to relieve mild pain or strain ... activities. Choose either the rigid or the ... amount of support. Washable and breathable, the ...
Medicine Products: